Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 1
2011 1
2012 1
2013 1
2016 3
2017 1
2018 1
2019 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

9 results

Results by year

Filters applied: . Clear all
Page 1
Direkte orale Antikoagulantien.
Merki R, Schwarb H, Tsakiris DA. Merki R, et al. Among authors: schwarb h. Ther Umsch. 2016;73(10):613-617. doi: 10.1024/0040-5930/a000834. Ther Umsch. 2016. PMID: 28045365 Review. German. No abstract available.
[Myelodysplastic Syndromes].
Stehle G, Schwarb H, Passweg JR. Stehle G, et al. Among authors: schwarb h. Ther Umsch. 2019;76(9):497-502. doi: 10.1024/0040-5930/a001130. Ther Umsch. 2019. PMID: 32157972 German.
[Chronic Lymphocytic Leukemia].
Schwarb H, Heim D. Schwarb H, et al. Ther Umsch. 2019;76(9):516-522. doi: 10.1024/0040-5930/a001129. Ther Umsch. 2019. PMID: 32157962 German.
Long-term outcome of dasatinib first-line treatment in gastrointestinal stromal tumor: A multicenter, 2-stage phase 2 trial (Swiss Group for Clinical Cancer Research 56/07).
Montemurro M, Cioffi A, Dômont J, Rutkowski P, Roth AD, von Moos R, Inauen R, Toulmonde M, Burkhard RO, Knuesli C, Bauer S, Cassier P, Schwarb H, Le Cesne A, Koeberle D, Bärtschi D, Dietrich D, Biaggi C, Prior J, Leyvraz S. Montemurro M, et al. Among authors: schwarb h. Cancer. 2018 Apr 1;124(7):1449-1454. doi: 10.1002/cncr.31234. Epub 2018 Jan 9. Cancer. 2018. PMID: 29315500 Free article. Clinical Trial.
Bendamustine, lenalidomide and dexamethasone (BRd) has high activity as 2nd -line therapy for relapsed and refractory multiple myeloma - a phase II trial.
Mey UJ, Brugger W, Schwarb H, Pederiva S, Schwarzer A, Dechow T, Jehner P, Rauh J, Taverna CJ, Schmid M, Schmidt-Hieber M, Doerfel S, Fischer N, Ruefer A, Ziske C, Knauf W, Cathomas R, von Moos R, Hitz F, Sauter R, Hiendlmeyer E, Cantoni N, Bargetzi M, Driessen C. Mey UJ, et al. Among authors: schwarb h. Br J Haematol. 2017 Mar;176(5):770-782. doi: 10.1111/bjh.14481. Epub 2016 Dec 16. Br J Haematol. 2017. PMID: 27983764 Free article. Clinical Trial.